Latest filing published 19 Aug 2024 for Diamyd Medical Aktiebolag, €1,481.
No signal scores available.
Christoph Nowak appears in our data through filings on Diamyd Medical Aktiebolag shares, published by Finansinspektionen. In total, 7 filings cover trades dated from 27 June 2023 to 19 August 2024.
Sales make up the whole of the open-market record (2 sales, €2,390). So far in 2024, the count stands at no purchases and 2 sales.
The newest entry dates from 19 August 2024: an open-market sale of €909, in Diamyd Medical Aktiebolag. Half of the filings or more reach the Finansinspektionen feed on the day of the trade. Under the Market Abuse Regulation, managers have three business days to notify their trades. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations